New drug slows prostate-cancer progression.
van der Boon
Jeroen
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077868:Atrasentan; D002986:Clinical Trials as Topic; D018450:Disease Progression; D019332:Endothelin-1 / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011759:Pyrrolidines
D000970:Antineoplastic Agents; D019332:Endothelin-1; D011759:Pyrrolidines; D000077868:Atrasentan